Does the blood-brain barrier play a role in glaucoma?

被引:70
|
作者
Grieshaber, Matthias C. [1 ]
Flammer, Josef [1 ]
机构
[1] Univ Basel Hosp, Dept Ophthalmol, CH-4031 Basel, Switzerland
关键词
basement membrane; blood-brain barrier; endothelin-1; glaucoma; matrix metalloproteinase; optic nerve head; optic disk hemorrhage; tight-junction; vascular dysregulation;
D O I
10.1016/j.survophthal.2007.08.005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The optic nerve head, although part of the central nervous system, lacks classical blood-brain barrier properties. The tissue of Elschnig does not totally separate the optic nerve head from fenestrated peripapillary choriocapillaries. The microvessels in the prelaminar region of the optic nerve head have less effective barriers than those in the laminar or retrolaminar regions. In glaucoma, the blood-brain barrier in the optic nerve head may even be weaker. Incomplete blood-brain barrier renders circulating molecules, such as endothelin-1 (ET-1), direct access to smooth vascular muscle cells and pericytes both in the prelaminar part of the optic nerve head and to adjacent retinal tissue. This potentially leads to some vasoconstriction as observed in the peri-papillary retinal vessel in glaucoma patients. In extreme situations, this may provoke retinal vein occlusion. The direct access of these molecules also influences the barrier function. If, simultaneously, ET-1 reduces endothelial tight-junctions and matrix-metalloproteinase (MMP)-9 degrades the basement membrane, not only macromolecules but even red blood cells may cross the blood-brain barrier and lead to what is clinically observed as optic disk hemorrhages.
引用
收藏
页码:S115 / S121
页数:7
相关论文
共 50 条
  • [41] DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion
    Zhu, Mingxia
    Xing, Dong
    Lu, Zhihong
    Fan, Yanhong
    Hou, Wugang
    Dong, Hailong
    Xiong, Lize
    Dong, Hui
    NEUROSCIENCE RESEARCH, 2015, 96 : 14 - 19
  • [42] Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition
    Parvez, Md Masud
    Sadighi, Armin
    Ahn, Yeseul
    Keller, Steve F.
    Enoru, Julius O.
    PHARMACEUTICS, 2023, 15 (10)
  • [43] Blood-brain barrier: Role of brain endothelial surface charge and glycocalyx
    Johansson, BB
    ISCHEMIC BLOOD FLOW IN THE BRAIN, 2001, 6 : 33 - 38
  • [44] DOES CANDESARTAN REDUCE BLOOD-BRAIN BARRIER PERMEABILITY IN TRAUMATIC BRAIN INJURY?
    Eslami, M.
    Koubanani, S. Khosravi
    Shafa, S.
    Khaksari, M.
    Soltani, Z.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 761 - 761
  • [45] Blood-brain barrier Part III: Therapeutic approaches to cross the blood-brain barrier and target the brain
    Weiss, N.
    Miller, F.
    Cazaubon, S.
    Couraud, P. -O.
    REVUE NEUROLOGIQUE, 2010, 166 (03) : 284 - 288
  • [46] Heterogeneity of the blood-brain barrier
    Wilhelm, Imola
    Nyul-Toth, Adam
    Suciu, Maria
    Hermenean, Anca
    Krizbai, Istvan A.
    TISSUE BARRIERS, 2016, 4 (01):
  • [47] Blood-brain barrier genomics
    Li, JY
    Boado, RJ
    Pardridge, WM
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (01) : 61 - 68
  • [48] Peptides and the blood-brain barrier
    Banks, William A.
    PEPTIDES, 2015, 72 : 16 - 19
  • [49] Hormones and the blood-brain barrier
    Hampl, Richard
    Bicikova, Marie
    Sosvorova, Lucie
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2015, 21 (03) : 159 - 164
  • [50] Trastuzumab and blood-brain barrier
    Platini, Christian
    BULLETIN DU CANCER, 2007, 94 (10) : 857 - 859